Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
20,416.57
+130.45
0.64%
Nifty
6,220.95
+33.65
0.54%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
RGESS
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Surya Pharmaceutical Ltd
BSE: 532516 | NSE: SURYAPHARM | ISIN: INE249G01020
Market Cap: [Rs.Cr.] 24 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Discuss this stock
Products & Services
Mar-2012
Mar-2011
Mar-2010
Mar-2009
Mar-2008
Mar-2007
Mar-2006
Mar-2005
Mar-2004
Mar-2003
Product Name
Unit
% of Stock
% Cap. Util.
Inst. Prod. Cap
Prodn
Sales Qty
Sales (Cr.)
Sales (Rs.) / Unit
Sale of Products
NA
99.9
0.0
0
0
0
1,647.74
-
Other Operating Revenue
NA
0.1
0.0
0
0
0
2.37
-
Phyto Chemicals
MT
0.0
0.0
0
0
0
0.00
-
Menthol
MT
0.0
0.0
0
0
0
0.00
-
Bulk Drugs
MT
0.0
0.0
0
0
0
0.00
-
Dry Syrups
No
0.0
0.0
0
0
0
0.00
-
Formulation
No
0.0
0.0
0
0
0
0.00
-
Tablets
No
0.0
0.0
0
0
0
0.00
-
India Infoline Research
Company
|
Sectors
No Related Research Found
Related News
Company
|
Sector
|
Latest
18-Feb-13
Surya Pharmaceutical reports net loss of Rs 77.94 crore in the December 2012 quarter
15-Nov-12
Surya Pharmaceutical reports net loss of Rs 78.00 crore in the September 2012 quarter
17-Aug-12
Surya Pharmaceutical reports net loss of Rs 87.81 crore in the June 2012 quarter
09-Jul-12
Surya Pharmaceutical's director resigns
16-May-12
Surya Pharmaceutical's directors resign
15-May-12
Surya Pharmaceutical reports net loss of Rs 110.75 crore in the March 2012 quarter
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds.
99,966.47
69.45
12.33
27.45
26.1
27.0
0.01
Dr Reddy's Labs
35,282.65
27.88
4.63
18.79
14.3
16.6
0.25
Cipla
34,095.15
22.27
4.52
14.11
15.9
19.8
0.03
Ranbaxy Labs.
19,947.05
0.00
10.38
72.87
0.0
0.0
2.38
Wockhardt
19,705.77
117.38
163.78
12.82
237.0
30.3
2.09
Cadila Health.
16,756.95
40.62
6.57
18.45
28.4
24.2
0.40
Glenmark Pharma.
15,498.19
40.15
6.14
23.94
12.7
11.7
0.39
Piramal Enterp.
10,037.23
0.00
0.95
23.66
0.8
2.1
0.07
Ipca Labs.
7,378.91
22.19
5.85
10.09
24.2
23.7
0.49
Torrent Pharma.
6,230.57
11.65
4.78
11.66
29.6
25.5
0.48
Biocon
5,708.00
19.90
2.59
12.20
12.6
13.6
0.08
Aurobindo Pharma
5,598.32
13.31
2.24
22.89
10.7
8.8
1.01
Strides Arcolab
5,198.17
35.44
3.79
16.20
5.1
5.7
0.97
Mylan Lab.
3,273.19
6.80
1.77
0.00
26.9
26.1
0.59
Alembic Pharma
2,470.29
15.69
5.37
5.60
39.5
27.7
1.07
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Alka Goyal , Executive Director
Rajiv Goyal , Chairman & Managing Director
D P Singhal , Independent Director
S K Yadav , Additional Director
Company Head Office / Quarters:
1596 1st Floor,
Bhagirath Palace,
Delhi,
Delhi-110006
Phone :
Fax :
E-mail :
sales@suryapharma.com
rajivg@suryapharma.com
Web :
http://www.suryapharma.com
Registrars:
Big Share Services Pvt Ltd
E-2/3 Saki Vihar Rd
Ansa Indl Estate
Saki Naka Andheri-E
Mumbai - 400 072
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
No data found
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Opening :
Just Dial
Issue Open :
Onesource Techm.
View full month IPO calendar
Economic Events
Rightmove House Prices (YoY)
Fed's Evans Speaks on Economy in Chicago
View full month Economic Events calendar
Results
India Cements | Voltas | Apollo Hospitals | Future Retail
View full month Results calendar